Related Experiment Video
Updated: Jun 17, 2025
A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
Testing the PEST hypothesis using relevant Rett mutations in MeCP2 E1 and E2 isoforms
Ladan Kalani1, Bo-Hyun Kim1, Alberto Ruiz de Chavez2
1Department of Biochemistry and Microbiology, University of Victoria, 3800 Finnerty Rd, Victoria, BC V8W 2Y2, Canada.
Abstract:
Mutations in methyl-CpG binding protein 2 (MeCP2), such as the T158M, P152R, R294X, and R306C mutations, are responsible for most Rett syndrome (RTT) cases. These mutations often result in altered protein expression that appears to correlate with changes in the nuclear size; however, the molecular details of these observations are poorly understood. Using a C2C12 cellular system expressing human MeCP2-E1 isoform as well as mouse models expressing these mutations, we show that T158M and P152R result in a decrease in MeCP2 protein, whereas R306C has a milder variation, and R294X resulted in an overall 2.5 to 3 fold increase. We also explored the potential involvement of the MeCP2 PEST domains in the proteasome-mediated regulation of MeCP2. Finally, we used the R294X mutant to gain further insight into the controversial competition between MeCP2 and histone H1 in the chromatin context. Interestingly, in R294X, MeCP2 E1 and E2 isoforms were differently affected, where the E1 isoform contributes to much of the overall protein increase observed, while E2 decreases by half. The modes of MeCP2 regulation, thus, appear to be differently regulated in the two isoforms.
Insights
Mutations in methyl-CpG binding protein 2 (MeCP2) impact protein levels, affecting Rett syndrome (RTT) pathogenesis. Different mutations cause varied MeCP2 expression changes, influencing cellular mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Mutations in methyl-CpG binding protein 2 (MeCP2) are the primary cause of Rett syndrome (RTT).
- Observed alterations in MeCP2 protein expression and nuclear size changes lack detailed molecular understanding.
- The study investigates the impact of specific MeCP2 mutations on protein levels and cellular function.
Purpose of the Study:
- To quantify MeCP2 protein level changes caused by specific RTT-associated mutations (T158M, P152R, R294X, R306C).
- To explore the role of MeCP2 PEST domains in proteasomal degradation.
- To investigate the R294X mutant's effect on MeCP2 and histone H1 competition at chromatin.
Main Methods:
- Utilized a C2C12 cellular system expressing human MeCP2-E1.
- Employed mouse models carrying specific MeCP2 mutations.
- Analyzed MeCP2 protein expression levels and isoform-specific changes.
Main Results:
- T158M and P152R mutations decreased MeCP2 protein levels.
- R306C showed minor variations, while R294X increased MeCP2 protein 2.5-3 fold.
- The R294X mutation differentially affected MeCP2 E1 (increased) and E2 (decreased) isoforms, suggesting distinct regulatory mechanisms.
Conclusions:
- MeCP2 mutation-specific alterations in protein levels are demonstrated.
- The study provides insights into MeCP2 regulation, including potential PEST domain involvement and isoform-specific dynamics.
- Findings contribute to understanding the molecular basis of Rett syndrome pathogenesis.
